Cerebellar Cladophialophora bantiana infection in a patient with marginal zone lymphoma treated with immunochemotherapy including rituximab
Bone involvement in a patient with Hodgkin lymphoma producing granulocyte colony stimulating factor: PET imaging
Platelet transfusions for patients with haematological malignancies: who needs them?
Milestones in umbilical cord blood transplantation
Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies
Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations
Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients
A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia
The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin
Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia
Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study
Comparative proteomics reveals deficiency of SLC9A1 (sodium/hydrogen exchanger NHE1) in β-adducin null red cells
Methaemalbumin formation in sickle cell disease: effect on oxidative protein modification and HO-1 induction
NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease
Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes
Impairment of FOS mRNA induction by a translation inhibitor puromycin in granulocytes from myelodysplastic syndrome patients
Activated NK cells have a potential therapeutic role in sustaining donor engraftment following paediatric haematopoietic stem cell transplantation for non-malignant disease
A peroxisome proliferator-activated receptor gamma ( PPARG ) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling
Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial
TNFAIP3 abnormalities in MALT lymphoma with autoimmunity
Haematology: A Core Curriculum
43rd Advances in Haematology Course Organisers: J Apperley, N Cooper, C Millar12–16 September 2011 Hammersmith Conference Centre Hammersmith Hospital London, UK